| Ethical aspects of the expansion of neonatal screening programme due to technological advances. | |
| | |
MedLine Citation:
|
PMID: 22035141 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Abstract Many countries are considering the expansion of their newborn bloodspot screening programmes. Whereas some countries screen for very few conditions, others are planning to screen for dozens. While advances in technology may facilitate this expansion, they must not lead it at the expense of considerations of the possible harms of this expansion. This article reviews some of the potential disbenefits of this expansion and outlines the ethical issues that should be considered. |
| | |
Authors:
|
David Elliman |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-10-28 |
Journal Detail:
|
Title: Clinical chemistry and laboratory medicine : CCLM / FESCC Volume: - ISSN: 1434-6621 ISO Abbreviation: - Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-10-31 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9806306 Medline TA: Clin Chem Lab Med Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
UK Newborn Screening Programme Centre, Hospital for Children NHS Trust, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
Next Document: Preferentially immunoglobulin (IgG) subclasses production in primary Sjögren's syndrome patients.